Inventor · disambiguated record
Suixiong Cai
Also filed as: CAI SUIXIONG
11 granted patents·17 citations·filing 2011–2018
84Inventor score
Files withIMPACT THERAPEUTICS INC5SHENYANG SUNSHINE PHARMACEUTICAL CO LTD3IMPACT THERAPEUTICS SHANGHAI INC2CAI SUIXIONG1
Top patents by PatentIndex Score
11 records- 0180US11179392B2Solid pharmaceutical formulation of PARP inhibitors and use thereofIMPACT THERAPEUTICS INC·Filed 2016·Granted Nov 23, 2021·3 cites·7 claims
- 0280US10874670B2Substituted fused heteroaromatic compounds as kinase inhibitors and the use thereofIMPACT THERAPEUTICS INC·Filed 2018·Granted Dec 29, 2020·2 cites·19 claims
- 0378US9994566B2Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation method thereof and pharmaceutical use thereofSHENYANG SUNSHINE PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 12, 2018·6 cites·25 claims
- 0477US9102631B21-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereofIMPACT THERAPEUTICS INC·Filed 2012·Granted Aug 11, 2015·3 cites·3 claims
- 0575US11345710B2Imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-ones and the use thereofIMPACT THERAPEUTICS SHANGHAI INC·Filed 2018·Granted May 31, 2022·1 cites·20 claims
- 0671US10562889B2Process for the preparation of 1-(arylmethyl)quinazoline-2,4(1H,3H)-dionesIMPACT THERAPEUTICS INC·Filed 2017·Granted Feb 18, 2020·1 cites·20 claims
- 0765US10676468B2N-(3-heteroarylaryl)-4-arylarylcarboxamides and analogs as hedgehog pathway inhibitors and use thereofIMPACT THERAPEUTICS INC·Filed 2013·Granted Jun 9, 2020·1 cites·17 claims
- 0846US11547703B2Substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereofIMPACT THERAPEUTICS SHANGHAI INC·Filed 2018·Granted Jan 10, 2023·0 cites·20 claims
- 0937US9199983B23-aryl-6-aryl-[1,2,4]triazolo[4,3-α]pyridines as inhibitors of cell proliferation and the use thereofCAI SUIXIONG·Filed 2011·Granted Dec 1, 2015·0 cites·19 claims
- 1031US10149841B2Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereofSHENYANG SUNSHINE PHARMACEUTICAL CO LTD·Filed 2015·Granted Dec 11, 2018·0 cites·16 claims
- 1130US10100051B2Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparation method thereof and pharmaceutical use thereofSHENYANG SUNSHINE PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 16, 2018·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Suixiong Cai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →